InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Lindahl Richard S, 首席财务官. Officer active across 1 company, notably Emergent BioSolutions Inc.. Cumulatively, 23 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €98k. History available since 8 May 2021. The latest transaction was disclosed on 29 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lindahl Richard S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
3,964 股Common StockSEC:0001196632-26-000017:0
162,680 股0Common StockSEC:0001196632-26-000013:0
23,650 股@ US$8.4419.0% 占其流量Common StockSEC:0001196632-26-000009:0
683 股@ US$8.150.5% 占其流量Common StockSEC:0001196632-26-000006:0
46,155 股@ US$10.9247.4% 占其流量Common StockSEC:0001196632-26-000003:0
4,995 股@ US$9.6013.8% 占其流量Common StockSEC:0001196632-25-000004:0
2,733 股@ US$6.636.2% 占其流量Common StockSEC:0001367644-25-000138:0
146,888 股0Common StockSEC:0001367644-25-000051:0
16,916 股0Common StockSEC:0001367644-25-000030:0
15,000 股0Common StockSEC:0001367644-24-000164:0
2,733 股@ US$6.193.9% 占其流量Common StockSEC:0001367644-24-000105:0
9,037 股@ US$3.236.8% 占其流量Common StockSEC:0001367644-24-000021:0
4,012 股@ US$2.712.5% 占其流量Common StockSEC:0001367644-24-000008:0
24,616 股0Common StockSEC:0001367644-23-000122:0
6,154 股0Common StockSEC:0001367644-23-000068:0
1,074 股@ US$12.383.2% 占其流量Common StockSEC:0001367644-23-000057:0
444 股@ US$14.301.5% 占其流量Common StockSEC:0001367644-23-000035:0
101 股0Common StockSEC:0001367644-23-000014:0
31,417 股0Common StockSEC:0001367644-22-000042:0
516 股@ US$42.230.0047% mcap5.9% 占其流量Common StockSEC:0001367644-22-000032:0
1,836 股0Common StockSEC:0001367644-22-000020:0
3,000 股@ US$37.4610.9% 占其流量Common StockSEC:0001367644-21-000144:0
标准退出：2022年2月13日 (T+90)
1,054 股@ US$61.626.0% 占其流量Common StockSEC:0001367644-21-000079:0
23 条申报中的 23 条
About Lindahl Richard S
LINDAHL RICHARD S is Directeur Financier and EVP, Chief Financial Officer at Emergent BioSolutions Inc. Across 23 filings recorded, the 23 sampled filings cover the period from 2021-05-11 to 2026-06-10, with buys of EUR 98220 and sells of EUR 437987, and the most frequent transaction nature shown is Retenue fiscale.
